RJF — Laboratorio Reig Jofre SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual cashflow statement for Laboratorio Reig Jofre SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6.43	5.79	8.76	10.5	11.8
Depreciation
Non-Cash Items	4.63	-0.559	-8.62	-0.304	1.07
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5.54	-8.78	-5.06	-14.2	-4.91
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	22.5	14.5	16.1	19.1	31.3
Capital Expenditures	-15.9	-19.8	-11.4	-12.8	-20.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-14.8	-14.9	-1.32	-0.11	-11.2
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-30.7	-34.7	-12.7	-12.9	-32
Financing Cash Flow Items	1.43	6.6	1.53	0	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	9.62	13.7	-2.04	-7.16	5.59
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1.42	-6.53	1.39	-0.928	4.96